Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neurons are the fundamental structural and functional units of the brain and nervous system, responsible for receiving sensory input, processing information, and transmitting motor
commands through sophisticated electrical and chemical signaling mechanisms. These specialized cells form the cellular basis of all nervous system functions, including cognition,
memory, emotion, perception, and voluntary movement. The human brain contains approximately 86 billion neurons, each capable of connecting to thousands of other neurons through
synaptic connections, creating a vast network of over 100 trillion synapses[1].
A typical neuron consists of several distinct compartments, each with specialized functions:
¶ Cell Body (Soma)
The cell body, also known as the soma, contains the nucleus and majority of cellular organelles necessary for protein synthesis, energy metabolism, and maintenance of cellular
homeostasis. The soma typically measures 10-100 micrometers in diameter and serves as the metabolic center of the neuron. Within the soma, the nucleus contains the genetic material
(DNA) and regulates gene expression, while the cytoplasm houses mitochondria for energy production, the endoplasmic reticulum and Golgi apparatus for protein synthesis and
processing, and the cytoskeleton for structural support[2].
Dendrites are branching extensions that emerge from the cell body and form the primary receptive surface of the neuron. These structures are covered with thousands of small
protrusions called [dendritic spines[/entities/[dendritic-spines[/entities/[dendritic-spines[/entities/[dendritic-spines[/entities/[dendritic-spines--TEMP--/entities)--FIX--, which receive synaptic inputs from other neurons. Dendrites integrate incoming signals through both temporal and spatial summation, allowing
neurons to weigh the relative importance of different inputs. The extensive branching pattern of dendrites can create thousands of synaptic connections, enabling complex
integration of information[3].
The axon is a single, typically long process that transmits electrical signals away from the cell body toward target cells. Axons can range in length from a few millimeters to over
a meter (as in [motor neurons[/cell-types/[motor-neurons[/cell-types/[motor-neurons[/cell-types/[motor-neurons[/cell-types/[motor-neurons--TEMP--/cell-types)--FIX-- that extend from the [spinal cord[/brain-regions/[spinal-cord[/brain-regions/[spinal-cord[/brain-regions/[spinal-cord[/brain-regions/[spinal-cord--TEMP--/brain-regions)--FIX-- to muscles). The axon is surrounded by a myelin sheath, which is formed by
[oligodendrocytes[/cell-types/[oligodendrocytes[/cell-types/[oligodendrocytes[/cell-types/[oligodendrocytes[/cell-types/[oligodendrocytes--TEMP--/cell-types)--FIX-- in the central nervous system and Schwann cells in the peripheral nervous system. This myelin insulation enables saltatory
conduction, dramatically increasing the speed of electrical signal transmission[4].
Synapses are specialized junctions where neurons communicate with each other or with effector cells such as muscle fibers. Each neuron typically forms 1,000 to 10,000 synapses,
allowing for massive parallel information processing. Synaptic transmission can be either electrical (through gap junctions) or chemical (through neurotransmitter release).
Chemical synapses are the most common type in the vertebrate nervous system and are primary targets of pathological changes in neurodegenerative diseases[5].
- Sensory neurons: Transduce physical stimuli (light, sound, touch) into neural signals
- Motor neurons: Transmit commands from the central nervous system to effector organs
- Interneurons: Process and integrate information within local neural circuits
- Glutamatergic neurons: Use [glutamate[/entities/[glutamate[/entities/[glutamate[/entities/[glutamate[/entities/[glutamate--TEMP--/entities)--FIX-- as the primary excitatory neurotransmitter
- GABAergic neurons: Use GABA as the primary inhibitory neurotransmitter
- Cholinergic neurons: Use [acetylcholine[/entities/[acetylcholine[/entities/[acetylcholine[/entities/[acetylcholine[/entities/[acetylcholine--TEMP--/entities)--FIX-- for neuromuscular transmission and cognitive functions
- Dopaminergic neurons: Use [dopamine[/entities/[dopamine[/entities/[dopamine[/entities/[dopamine[/entities/[dopamine--TEMP--/entities)--FIX-- for motor control, reward, and motivation
- Serotonergic neurons: Use [serotonin[/entities/[serotonin[/entities/[serotonin[/entities/[serotonin[/entities/[serotonin--TEMP--/entities)--FIX-- for mood regulation and sleep
Neurons communicate through electrical signals called action potentials - brief, stereotypic depolarizations that propagate along the axon. Action potentials are generated by the
opening of voltage-gated sodium channels, followed by voltage-gated potassium channels, creating a rapid upstroke and subsequent repolarization. This all-or-none phenomenon allows
for faithful transmission of information over long distances[6].
At synapses, action potentials trigger the release of neurotransmitters from presynaptic terminals. These chemical messengers diffuse across the synaptic cleft and bind to
receptors on the postsynaptic membrane, either exciting or inhibiting the target neuron. Key neurotransmitters include glutamate (excitatory), GABA (inhibitory), acetylcholine,
dopamine, and serotonin. Dysregulation of synaptic transmission is a hallmark of neurodegenerative diseases[7].
Neurons in [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX-- exhibit several characteristic pathological changes:
- Synaptic loss: The earliest and most robust correlate of cognitive decline. Synaptic density decreases by 25-30% in [mild cognitive impairment[/diseases/[mci[/diseases/[mci[/diseases/[mci[/diseases/[mci--TEMP--/diseases)--FIX-- and up to 50% in [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX-- dementia. This loss correlates more strongly with cognitive impairment than amyloid plaque or neurofibrillary tangle burden[8].
- [Tau[/entities/[tau-protein[/entities/[tau-protein[/entities/[tau-protein[/entities/[tau-protein--TEMP--/entities)--FIX--(/proteins/tau pathology: Neurofibrillary tangles composed of hyperphosphorylated tau] protein accumulate first in entorhinal [cortex[/brain-regions/[cortex[/brain-regions/[cortex[/brain-regions/[cortex[/brain-regions/[cortex--TEMP--/brain-regions)--FIX-- and [hippocampus[/brain-regions/[hippocampus[/brain-regions/[hippocampus[/brain-regions/[hippocampus[/brain-regions/[hippocampus--TEMP--/brain-regions)--FIX--, regions critical for memory, before spreading to cortical areas.
- Amyloid toxicity: While [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- plaques are a defining feature, soluble oligomeric forms of [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- are believed to be more toxic to synapses and neurons.
- Dendritic spine loss: Caused by [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- oligomers and tau], leading to disruption of synaptic plasticity[9].
- Dopaminergic neuron loss: Selective degeneration of [substantia nigra[/brain-regions/[substantia-nigra[/brain-regions/[substantia-nigra[/brain-regions/[substantia-nigra[/brain-regions/[substantia-nigra--TEMP--/brain-regions)--FIX-- pars compacta neurons that project to the [striatum[/brain-regions/[striatum[/brain-regions/[striatum[/brain-regions/[striatum[/brain-regions/[striatum--TEMP--/brain-regions)--FIX--, leading to motor symptoms
- Lewy bodies: Intracellular inclusions containing [alpha-synuclein[/proteins/[alpha-synuclein[/proteins/[alpha-synuclein[/proteins/[alpha-synuclein[/proteins/[alpha-synuclein--TEMP--/proteins)--FIX-- that accumulate in surviving neurons
- Axonal degeneration: Often precedes cell body death, contributing to disease progression[10]
- Motor neuron degeneration: Progressive loss of both upper motor neurons (cortical) and lower motor neurons (spinal)
- [TDP-43[/entities/[tdp-43[/entities/[tdp-43[/entities/[tdp-43[/entities/[tdp-43--TEMP--/entities)--FIX-- pathology: Aggregation of [TDP-43[/entities/[tdp-43[/entities/[tdp-43[/entities/[tdp-43[/entities/[tdp-43--TEMP--/entities)--FIX-- protein in the cytoplasm of affected neurons
- [excitotoxicity[/entities/[excitotoxicity[/entities/[excitotoxicity[/entities/[excitotoxicity[/entities/[excitotoxicity--TEMP--/entities)--FIX--: Excessive glutamate signaling through AMPA and [NMDA receptor[/entities/[nmda-receptor[/entities/[nmda-receptor[/entities/[nmda-receptor[/entities/[nmda-receptor--TEMP--/entities)--FIX-- receptor] receptor]] receptors leads to calcium overload and cell death[11]
- Striatal neuron loss: Medium spiny neurons in the striatum are particularly vulnerable
- Mutant [huntingtin[/proteins/[huntingtin[/proteins/[huntingtin[/proteins/[huntingtin[/proteins/[huntingtin--TEMP--/proteins)--FIX--: The [huntingtin[/proteins/[huntingtin[/proteins/[huntingtin[/proteins/[huntingtin[/proteins/[huntingtin--TEMP--/proteins)--FIX-- protein with polyglutamine expansions becomes toxic through gain-of-function mechanisms
- Nuclear inclusions: Mutant [huntingtin[/proteins/[huntingtin[/proteins/[huntingtin[/proteins/[huntingtin[/proteins/[huntingtin--TEMP--/proteins)--FIX-- accumulates in neuronal nuclei, disrupting gene transcription[12]
Programmed cell death pathways are activated in many neurodegenerative conditions. The intrinsic (mitochondrial) pathway is triggered by cellular stress signals, leading to
cytochrome c release and caspase-9 activation. The extrinsic pathway involves death receptor activation and caspase-8. While apoptosis is a regulated process, excessive activation
contributes to progressive neuronal loss[13].
A programmed form of necrosis mediated by receptor-interacting protein kinases (RIPK1, RIPK3) and mixed lineage kinase domain-like protein (MLKL). [necroptosis[/entities/[necroptosis[/entities/[necroptosis[/entities/[necroptosis[/entities/[necroptosis--TEMP--/entities)--FIX-- is increasingly recognized in Alzheimer's, [Parkinson]'s, and ALS, and may represent a therapeutic target[14].
An iron-dependent form of non-apoptotic cell death characterized by lipid peroxidation. Evidence suggests [ferroptosis[/mechanisms/[ferroptosis[/mechanisms/[ferroptosis[/mechanisms/[ferroptosis[/mechanisms/[ferroptosis--TEMP--/mechanisms)--FIX-- contributes to neuronal loss in [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX-- and [Parkinson's disease[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons--TEMP--/diseases)--FIX--. The system Xc-/glutathione/GPX4 axis is the key regulatory pathway[15].
Neurons rely heavily on [autophagy[/entities/[autophagy[/entities/[autophagy[/entities/[autophagy[/entities/[autophagy--TEMP--/entities)--FIX-- to clear misfolded proteins and damaged organelles. Impairment of the autophagy-lysosomal pathway and [ubiquitin-proteasome system[/cell-types/[ubiquitin-proteasome-system[/cell-types/[ubiquitin-proteasome-system[/cell-types/[ubiquitin-proteasome-system[/cell-types/[ubiquitin-proteasome-system--TEMP--/cell-types)--FIX-- leads to accumulation of toxic protein aggregates, contributing to neurodegeneration[16].
- BDNF (Brain-Derived Neurotrophic Factor): Supports neuron survival and synaptic plasticity
- NGF (Nerve Growth Factor): Critical for cholinergic neuron survival
- GDNF (Glial Cell Line-Derived Neurotrophic Factor): Protects [dopaminergic neurons[/cell-types/[dopaminergic-neurons-snpc[/cell-types/[dopaminergic-neurons-snpc[/cell-types/[dopaminergic-neurons-snpc[/cell-types/[dopaminergic-neurons-snpc--TEMP--/cell-types)--FIX--
- AMPA receptor modulators: Reduce excitotoxicity
- [NMDA receptor[/entities/[nmda-receptor[/entities/[nmda-receptor[/entities/[nmda-receptor[/entities/[nmda-receptor--TEMP--/entities)--FIX-- receptor] receptor] receptor] receptor antagonists: Prevent calcium overload (though with significant side effects)
- Sodium channel blockers: Reduce pathological neuronal firing
- Mitochondrial protectors: CoQ10, creatine, nicotinamide
- Antioxidants: Reduce [oxidative stress[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress[/mechanisms/[oxidative-stress--TEMP--/mechanisms)--FIX--
- Energy metabolism enhancers: Improve glucose utilization
The study of Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [Cell Types Index[/[cell-types[/[cell-types[/[cell-types[/[cell-types[/[cell-types[/[cell-types[/[cell-types[/cell-types
- [Brain Regions Index[/[brain-regions[/[brain-regions[/[brain-regions[/[brain-regions[/[brain-regions[/[brain-regions[/[brain-regions[/brain-regions
- [Neurodegenerative Diseases[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/diseases
Neurons are the fundamental computational units of the nervous system, specializing in electrical and chemical signal transmission. The diversity of neuronal types, their intricate connectivity, and the complexity of synaptic transmission underlie all aspects of brain function. In neurodegenerative diseases, selective neuronal populations undergo progressive dysfunction and death, leading to the characteristic cognitive, motor, and behavioral symptoms of these disorders. Understanding the molecular mechanisms of neuronal vulnerability, including mitochondrial dysfunction, protein aggregation, and excitotoxicity, is essential for developing neuroprotective strategies. Advances in stem cell technologies and neuronal reprogramming offer potential avenues for neuronal replacement therapy in the future.
Neurons are the fundamental computational units of the nervous system, and their dysfunction underlies all neurodegenerative diseases. The selective vulnerability of specific neuronal populations—such as cholinergic neurons in the basal forebrain in Alzheimer's disease, dopaminergic neurons in the substantia nigra in Parkinson's disease, and motor neurons in ALS—reflects intrinsic molecular and structural differences that determine susceptibility to pathological insults. Understanding the mechanisms of neuronal death, including excitotoxicity, oxidative stress, mitochondrial dysfunction, and impaired proteostasis, is essential for developing neuroprotective therapies. Emerging approaches such as gene therapy, stem cell replacement, and targeted small molecules aim to preserve or replace vulnerable neurons, offering hope for disease modification in neurodegenerative disorders.
- : Spruston N. Pyramidal neurons: dendritic structure and synaptic integration. Nat Rev Neurosci. 2008;9(3]:206-221. DOI:10.1038/nrn2286
- : Debanne D, Campanac E, Bialowas A, Carlier E, Alcaraz G. Axon physiology. Physiol Rev. 2011;91(2]:555-602. DOI:10.1152/physrev.00048.2009
- : Sudhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Nature. 2009;457(7226]:651-657. DOI:10.1038/nature07620
- : Hille B. Ion Channels of Excitable Membranes, 3rd ed. Sinauer Associates; 2001.
- : Tabrizi SJ, Flower MD, Ross CA, Wild EJ. Huntington's Disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol. 2020;16(10]:529-546. DOI:10.1038/s41582-020-0389-4
- : Selkoe DJ. Alzheimer's Disease is a synaptic failure. Science. 2002;298(5594]:789-791. DOI:10.1126/science.1074069
- : Querfurth HW, LaFerla FM. Alzheimer's Disease. N Engl J Med. 2010;362(4]:329-344. DOI:10.1056/NEJMra0909142
- : Kalia LV, Lang AE. [Parkinson's disease[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons--TEMP--/diseases)--FIX--. Lancet. 2015;386(9996]:896-912. [DOI:10.1016/S0140-6736(14](https://doi.org/10.1016/S0140-6736(14)]61393-3
- : Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. DOI:10.1038/nrdp.2017.71
- : The [Huntington's disease[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway[/mechanisms/[huntington-pathway--TEMP--/mechanisms)--FIX-- Collaborative Research Project. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's Disease chromosomes. Cell. 1993;72(6]:971-983. [DOI:10.1016/0092-8674(93](https://doi.org/10.1016/0092-8674(93)]90585-E
- : Mattson MP. [apoptosis[/entities/[apoptosis[/entities/[apoptosis[/entities/[apoptosis[/entities/[apoptosis--TEMP--/entities)--FIX-- in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1(2]:120-129. DOI:10.1038/35040009
- : Galluzzi L, Kepp O, Chan FK, Kroemer G. necroptosis: mechanisms and relevance to disease. Annu Rev Pathol. 2017;12:103-130. DOI:10.1146/annurev-pathol-052016-100247
- : Dixon SJ, Stockwell BR. The role of iron and lipid peroxidation in ferroptosis. Cell Chem Biol. 2019;26(1]:18-28. DOI:10.1016/j.chembiol.2019.10.003
- : Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19(8]:983-997. DOI:10.1038/nm.3232
-
- [Neurodegenerative Diseases[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/diseases
-
- [Genes Index[/[genes[/[genes[/[genes[/[genes[/[genes[/[genes[/[genes[/genes
-
- [Mechanisms of Neurodegeneration[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/mechanisms
-
- [Proteins Index[/[proteins[/[proteins[/[proteins[/[proteins[/[proteins[/[proteins[/[proteins[/proteins## External Links
-
-
-